Ahzantive
Information about Ahzantive® for Patients and Healthcare Professionals
Ahzantive® (aflibercept)Package leaflet: Information for the adult patient
Ahzantive®40 mg/mlsolution forinjection ina vial
Ahzantive®40 mg/ml solution for injection in pre-filled syringe
Ahzantive® (aflibercept)Summary of Product Characteristics
Summary of Product Characteristics –Information for Health Care Professionals
Ahzantive®40 mg/mlsolution forinjection ina vial
Summary of Product Characteristics –Information for Health Care Professionals
Ahzantive®40 mg/ml solution for injection in pre-filled syringe
Patient booklet –your guide to Ahzantive® (aflibercept)
Prescriber Guide to intravitreal injections with Ahzantive® (aflibercept)
Prescriber Guide
Ahzantive®40 mg/ml solution for injection in a vial and40 mg/ml solution for injection in pre-filled syringe
Reporting of side effects
If you notice any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk
Please ensure that you provide the brand name, and the specific batch-number.
By reporting side effects you can help provide more information on the safety of this medicine.
Alternatively you may report side effects by email to:
medinfo@formycon.com
The data processing is in accordance with the legal requirements. Further information can be found here.
